PTX 0.00% 4.0¢ prescient therapeutics limited

From the ASX ann 15-2-16 PTX Chairman, Steven Engle said, “After...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 629 Posts.
    lightbulb Created with Sketch. 33
    From the ASX ann 15-2-16

    PTX Chairman, Steven Engle said, “After a broad search for the best possible leader to take PTX forward, it became very clear that Steven was the ideal candidate for the role. As a non-executive director of the Company since its founding, he understands the business strategy well, and moreover, has a deep appreciation and knowledge of our science and its application in the clinical setting. We are delighted to have him as Managing Director.

    Steve is an original director and no doubt the financial engineer behind the reverse merger into Virax. He has been roadshowing PTX in Aus and the US for some time now. If you couldn't get a chace to see/hear/meet him at the AGM, here he is presenting PTX in January http://noble.mediasite.com/mediasite/Play/077aa262f93f4152891d344b839c310f1d
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.